Use of Impella cardiac axial flow pump for cardiogenic shock (A newer alternative)-How good is the evidence?

MLA

Bhat, Rafiq Ahmed, et al. “Use of Impella Cardiac Axial Flow Pump for Cardiogenic Shock (A Newer Alternative)-How Good Is the Evidence?” Biocell, vol. 46, no. 4, Apr. 2022, pp. 1139–50. EBSCOhost, https://doi.org/10.32604/biocell.2022.016833.

APA

Bhat, R. A., Ali, S. M., Hussenbocus, Y. A. A. M., Rathi, A., Bhat, J. A., Khan, A. A., Maqbool, S., Saqib Iqbal, R., Islam, M. M., Yongsheng Qu, You Zhang, Yuxiao Sun, Wentao Xiao, Tibrewal, A., & Chuanyu Gao. (2022). Use of Impella cardiac axial flow pump for cardiogenic shock (A newer alternative)-How good is the evidence? Biocell, 46(4), 1139–1150. https://doi.org/10.32604/biocell.2022.016833

Chicago

Bhat, Rafiq Ahmed, Syed Manzoor Ali, Yoosuf Ali Ashraf Muhammad Hussenbocus, Akanksha Rathi, Javaid Akhter Bhat, Abdul Aleem Khan, Syed Maqbool, et al. 2022. “Use of Impella Cardiac Axial Flow Pump for Cardiogenic Shock (A Newer Alternative)-How Good Is the Evidence?” Biocell 46 (4): 1139–50. doi:10.32604/biocell.2022.016833.